-
31.
公开(公告)号:US20080292700A1
公开(公告)日:2008-11-27
申请号:US12186853
申请日:2008-08-06
Applicant: Tien NGHIEM , Graham Jackson
Inventor: Tien NGHIEM , Graham Jackson
CPC classification number: A61K31/35 , A61K9/2018 , A61K9/2054 , A61K9/2846
Abstract: A controlled release pharmaceutical composition comprises (a) topiramate or a pharmaceutically acceptable salt thereof, (b) a first intelligent polymer component; and (c) a second intelligent polymer component having opposite wettability characteristics to the first intelligent polymer component. The polymer components are effective for controlled release of the pharmaceutically active substance from the composition.
Abstract translation: 控释药物组合物包含(a)托吡酯或其药学上可接受的盐,(b)第一智能聚合物组分; 和(c)具有与第一智能聚合物组分相反润湿特性的第二智能聚合物组分。 聚合物组分对于从组合物中控制释放药物活性物质是有效的。
-
公开(公告)号:US20080081068A1
公开(公告)日:2008-04-03
申请号:US11766239
申请日:2007-06-21
Applicant: Werner OBEREGGER , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Inventor: Werner OBEREGGER , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
CPC classification number: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号:US20080038345A1
公开(公告)日:2008-02-14
申请号:US11774109
申请日:2007-07-06
Applicant: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Inventor: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
IPC: A61K9/22 , A61K31/135 , A61P25/00
CPC classification number: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号:US07241805B2
公开(公告)日:2007-07-10
申请号:US11475252
申请日:2006-06-27
Applicant: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Ashty Saleh
Inventor: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Ashty Saleh
IPC: A61K31/195 , A61K9/48
CPC classification number: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
Abstract translation: 本发明涉及包含安非他酮盐的药物组合物,制剂和药物,特别是包含有效量的安非他酮氢溴酸盐的改性释放片剂,以及使用安非他酮盐来制备治疗病症的药物。
-
公开(公告)号:US20050000151A1
公开(公告)日:2005-01-06
申请号:US10856724
申请日:2004-05-28
Applicant: Graham Jackson
Inventor: Graham Jackson
IPC: C10L1/192 , C08G8/00 , C08G61/02 , C10L1/02 , C10L1/14 , C10L1/16 , C10L1/18 , C10L1/198 , C10L1/22 , C10L10/14
CPC classification number: C10L1/1981 , C08G61/02 , C10L1/143 , C10L1/1658 , C10L1/1973 , C10L1/1985 , C10L1/2222 , C10L1/224
Abstract: A fuel oil composition comprising a fuel oil and 0.1 to 10,000 ppm of a polymeric condensation product which is formed by the reaction of an aliphatic aldehyde or ketone, or a reactive equivalent, with either (i) a straight or branched chain C1-C7 alkyl ester of p-hydroxybenzoic acid, or with (ii) a branched chain C8-C16 alkyl ester of p-hydroxybenzoic acid, or with (iii) a mixture of long chain C8-C18 alkyl esters of p-hydroxybenzoic acid, at least one of said alkyls being branched. The polymeric condensation product improves the cold flow characteristics of the fuel oil.
Abstract translation: 一种燃料油组合物,其包含燃料油和0.1至10,000ppm的聚合缩合产物,其通过脂族醛或酮或反应性当量与(i)直链或支链C 1 -C 7烷基 对 - 羟基苯甲酸的酯或与(ii)对羟基苯甲酸的支链C 8 -C 16烷基酯或(iii)对羟基苯甲酸的长链C8-C18烷基酯的混合物,至少一种 的所述烷基是支链的。 聚合物缩合产物改善燃料油的冷流特性。
-
36.
公开(公告)号:US06664404B2
公开(公告)日:2003-12-16
申请号:US10145049
申请日:2002-05-14
Applicant: Graham Jackson
Inventor: Graham Jackson
IPC: C11C100
CPC classification number: C11C3/06 , C07C67/03 , Y02P20/582 , C07C69/52 , C07C69/30
Abstract: An improved process for the manufacture of monoesters of polyhydroxyalcohols to high yields and high purities.
Abstract translation: 一种用于制备聚羟基醇单酯的高产率和高纯度的改进方法。
-
37.
公开(公告)号:US06251146B1
公开(公告)日:2001-06-26
申请号:US09203692
申请日:1998-12-02
Applicant: Graham Jackson
Inventor: Graham Jackson
IPC: C10L116
CPC classification number: C10L1/1691 , C10L1/143 , C10L1/1608 , C10L1/1616 , C10L1/1641 , C10L1/1658 , C10L1/1824 , C10L1/19 , C10L1/195 , C10L1/1963 , C10L1/1966 , C10L1/1973 , C10L1/1985 , C10L1/224 , C10L1/2437
Abstract: A mixture of petroleum waxes improves the low temperature flow properties of oils.
Abstract translation: 石油蜡的混合物改善了油的低温流动性能
-
公开(公告)号:US4977254A
公开(公告)日:1990-12-11
申请号:US388657
申请日:1989-08-02
Applicant: Nigel J. Homer , Graham Jackson , George H. Sankey , Philip J. Simpson
Inventor: Nigel J. Homer , Graham Jackson , George H. Sankey , Philip J. Simpson
Abstract: Sugars and partly protected sugar derivatives are chlorinated by reaction of unprotected hydroxyl groups with thionyl chloride to form a persulphite followed by decomposition of the sulphite groups to form chlorosulphites, displacement of the chlorosulphite groups and insertion of chlorine atoms at one or more positions, characterised in that formation and displacement of the chlorosulphite groups and insertion of chlorine atoms is effected by reaction with thionyl chloride in an inert solvent in the presence of a quaternary salt of the general formula:N.sup.+ R.sup.1 R.sup.2 R.sup.3 R.sup.4 Cl.sup.- (I)wherein R.sup.1, R.sup.2 and R.sup.3, which may be the same or different, each represent a lower alkyl group, and R.sup.4 represents a hydrocarbon group with at least seven carbon atoms; and, when the sugar or partly protected sugar derivative has more than three unprotected hydroxyl groups, the process comprises the following stages:(a) reaction of the sugar or partly protected sugar derivative with thionyl chloride in the presence of pyridine to form a persulphite;(b) isolation of the polysulphite to remove free pyridine; and(c) reaction of the isolated polysulphite with thionyl chloride in an inert solvent or suspension medium in the presence of a quaternary salt of the general formula (I).
-
公开(公告)号:US4751294A
公开(公告)日:1988-06-14
申请号:US818720
申请日:1986-01-14
Applicant: Graham Jackson
Inventor: Graham Jackson
Abstract: Sucralose (4-chloro-4-deoxy-.alpha.-D-galactopyranosyl 1,6-dichloro-1,6-dideoxy-.beta.-D-fructofuranoside) is thermally stabilized by co-crystallization with a nitrogenous base, for example niacinamide or an amino acid.
Abstract translation: 三氯蔗糖(4-氯-4-脱氧-α-D-吡喃半乳糖基1,6-二氯-1,6-二脱氧-β-D-呋喃果糖苷)通过与含氮碱例如烟酰胺或 氨基酸。
-
公开(公告)号:US08431526B2
公开(公告)日:2013-04-30
申请号:US13221417
申请日:2011-08-30
Applicant: Vincent Brian Croud , Graham Jackson , John Collinge
Inventor: Vincent Brian Croud , Graham Jackson , John Collinge
IPC: C07K14/00
CPC classification number: A61L2/16 , A01N37/16 , A23L3/3499 , A23L3/3508 , A23L3/3571 , A61L2/186 , A61L2202/24 , C11D3/386 , C11D3/3947 , C11D3/48 , C11D11/0041 , A01N2300/00 , A01N25/30 , A01N37/46 , A01N61/00 , A01N63/00 , A01N63/02 , A01N63/04 , A01N65/00
Abstract: The invention relates to compositions and methods for prion degradation, decontamination or disinfection. The composition comprises an oxidizing agent, one or more proteases and a surfactant such as an ionic surfactant/detergent. The method comprises contacting a prion contaminated entity with a prion-degrading composition comprising an effective amount of an oxidizing agent, an effective amount of at least one protease, and an effective amount of a surfactant. The components of the composition may be contacted with a prion-contaminated entity sequentially or simultaneously using an aqueous composition. Typically at least two different proteases are used for optimal efficacy. Preferably the oxidizing agent comprises peracetyl ions or a source thereof. The invention also relates to kits comprising the various reagents.
Abstract translation: 本发明涉及朊病毒降解,去污或消毒的组合物和方法。 组合物包含氧化剂,一种或多种蛋白酶和表面活性剂如离子表面活性剂/洗涤剂。 该方法包括使朊病毒污染的实体与包含有效量的氧化剂,有效量的至少一种蛋白酶和有效量的表面活性剂的朊病毒降解组合物接触。 组合物的组分可以使用水性组合物依次或同时与朊病毒污染的实体接触。 通常使用至少两种不同的蛋白酶来获得最佳疗效。 优选地,氧化剂包括全乙酰离子或其源。 本发明还涉及包含各种试剂的试剂盒。
-
-
-
-
-
-
-
-
-